Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' VERONESE ME' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 21 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. ZHU XY; VERONESE ME; IOCCO P; MCMANUS ME
      CDNA CLONING AND EXPRESSION OF A NEW FORM OF HUMAN ARYL SULFOTRANSFERASE

      International journal of biochemistry & cell biology
    2. TASSANEEYAKUL W; BIRKETT DJ; EDWARDS JW; VERONESE ME; TASSANEEYAKUL W; TUKEY RH; MINERS JO
      HUMAN CYTOCHROME-P450 ISOFORM SPECIFICITY IN THE REGIOSELECTIVE METABOLISM OF TOLUENE AND O-XYLENE, M-XYLENE AND P-XYLENE

      The Journal of pharmacology and experimental therapeutics
    3. RADOMINSKA A; DRAKE RR; ZHU XY; VERONESE ME; LITTLE JM; NOWELL S; MCMANUS ME; LESTER R; FALANY CN
      PHOTOAFFINITY-LABELING OF HUMAN RECOMBINANT SULFOTRANSFERASES WITH 2-AZIDOADENOSINE 3',5'-[5'-P-32]BISPHOSPHATE

      The Journal of biological chemistry
    4. MINERS JO; COULTER S; TUKEY RH; VERONESE ME; BIRKETT DJ
      CYTOCHROME P450, 1A2, AND 2C9 ARE RESPONSIBLE FOR THE HUMAN HEPATIC O-DEMETHYLATION OF R-NAPROXEN AND S-NAPROXEN

      Biochemical pharmacology
    5. HAINING RL; HUNTER AP; VERONESE ME; TRAGER WF; RETTIE AE
      ALLELIC VARIANTS OF HUMAN CYTOCHROME-P450 2C9 - BACULOVIRUS-MEDIATED EXPRESSION, PURIFICATION, STRUCTURAL CHARACTERIZATION, SUBSTRATE STEREOSELECTIVITY, AND PROCHIRAL SELECTIVITY OF THE WILD-TYPE AND I359L MUTANT FORMS

      Archives of biochemistry and biophysics
    6. MINERS JO; REES DLP; VALENTE L; VERONESE ME; BIRKETT DJ
      HUMAN HEPATIC CYTOCHROME-P450 2C9 CATALYZES THE RATE-LIMITING PATHWAYOF TORSEMIDE METABOLISM

      The Journal of pharmacology and experimental therapeutics
    7. TASSANEEYAKUL W; BIRKETT DJ; VERONESE ME; MCMANUS ME; TUKEY RH; MINERS JO
      DIRECT CHARACTERIZATION OF THE SELECTIVITY OF FURAFYLLINE AS AN INHIBITOR OF HUMAN CYTOCHROMES P450 1A1 AND 1A2

      Pharmacogenetics
    8. ANDERSSON T; MINERS JO; VERONESE ME; BIRKETT DJ
      DIAZEPAM METABOLISM BY HUMAN LIVER-MICROSOMES IS MEDIATED BY BOTH S-MEPHENYTOIN HYDROXYLASE AND CYP3A ISOFORMS

      British journal of clinical pharmacology
    9. ANDERSSON T; MINERS JO; VERONESE ME; BIRKETT DJ
      IDENTIFICATION OF HUMAN LIVER CYTOCHROME-P450 ISOFORMS MEDIATING SECONDARY OMEPRAZOLE METABOLISM

      British journal of clinical pharmacology
    10. BIRKETT DJ; REES D; ANDERSSON T; GONZALEZ FJ; MINERS JO; VERONESE ME
      IN-VITRO PROGUANIL ACTIVATION TO CYCLOGUANIL BY HUMAN LIVER-MICROSOMES IS MEDIATED BY CYP3A ISOFORMS AS WELL AS BY S-MEPHENYTOIN HYDROXYLASE

      British journal of clinical pharmacology
    11. VERONESE ME; BURGESS W; ZHU XY; MCMANUS ME
      FUNCTIONAL-CHARACTERIZATION OF 2 HUMAN SULFOTRANSFERASE CDNAS THAT ENCODE MONOAMINE-SULFATING AND PHENOL-SULFATING FORMS OF PHENOL SULFOTRANSFERASE - SUBSTRATE KINETICS, THERMAL-STABILITY AND INHIBITOR-SENSITIVITY STUDIES

      Biochemical journal
    12. VERONESE ME; BURGESS W; CRUICKSHANK D; SANSOM L; ZHU XY; MCMANUS ME
      HETEROLOGOUS SYSTEMS FOR EXPRESSION OF MAMMALIAN SULFOTRANSFERASES

      Chemico-biological interactions
    13. TASSANEEYAKUL W; BIRKETT DJ; MCMANUS ME; TASSANEEYAKUL W; VERONESE ME; ANDERSSON T; TUKEY RH; MINERS JO
      CAFFEINE METABOLISM BY HUMAN HEPATIC CYTOCHROMES P450 - CONTRIBUTIONSOF 1A2, 2E1 AND 3A ISOFORMS

      Biochemical pharmacology
    14. VERONESE ME; MINERS JO; REES DLP; BIRKETT DJ
      TOLBUTAMIDE HYDROXYLATION IN HUMANS - LACK OF BIMODALITY IN 106 HEALTHY-SUBJECTS

      Pharmacogenetics
    15. ANDERSSON T; LAGERSTROM PO; MINERS JO; VERONESE ME; WEIDOLF L; BIRKETT DJ
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR HUMAN LIVER MICROSOMAL OMEPRAZOLE METABOLISM

      Journal of chromatography. Biomedical applications
    16. ANDERSSON T; MINERS JO; VERONESE ME; TASSANEEYAKUL W; TASSANEEYAKUL W; MEYER UA; BIRKETT DJ
      IDENTIFICATION OF HUMAN LIVER CYTOCHROME-P450 ISOFORMS MEDIATING OMEPRAZOLE METABOLISM

      British journal of clinical pharmacology
    17. TASSANEEYAKUL W; BIRKETT DJ; VERONESE ME; MCMANUS ME; TUKEY RH; QUATTROCHI LC; GELBOIN HV; MINERS JO
      SPECIFICITY OF SUBSTRATE AND INHIBITOR PROBES FOR HUMAN CYTOCHROMES-P450 1A1 AND 1A2

      The Journal of pharmacology and experimental therapeutics
    18. TASSANEEYAKUL W; VERONESE ME; BIRKETT DJ; GONZALEZ FJ; MINERS JO
      VALIDATION OF 4-NITROPHENOL AS AN IN-VITRO SUBSTRATE PROBE FOR HUMAN LIVER CYP2E1 USING CDNA EXPRESSION AND MICROSOMAL KINETIC TECHNIQUES

      Biochemical pharmacology
    19. ZHU XY; VERONESE ME; BERNARD CCA; SANSOM LN; MCMANUS ME
      IDENTIFICATION OF 2 HUMAN BRAIN ARYL SULFOTRANSFERASE CDNAS

      Biochemical and biophysical research communications
    20. ZHU XY; VERONESE ME; SANSOM LN; MCMANUS ME
      MOLECULAR CHARACTERIZATION OF A HUMAN ARYL SULFOTRANSFERASE CDNA

      Biochemical and biophysical research communications
    21. BIRKETT DJ; MACKENZIE PI; VERONESE ME; MINERS JO
      IN-VITRO APPROACHES CAN PREDICT HUMAN DRUG-METABOLISM

      Trends in pharmacological sciences


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 09:35:26